Development of a High-Throughput Screening–Compatible Assay for the Discovery of Inhibitors of the AF4-AF9 Interaction Using AlphaScreen Technology

In Search of Targeted Therapies for Childhood Cancer

(2011) Crystal L. Mackall   Frontiers in Oncology

MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia

(2010) Sara C. Monroe et al.   EXPERIMENTAL HEMATOLOGY

New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays

(2010) Jonathan B. Baell et al.   JOURNAL OF MEDICINAL CHEMISTRY

The molecular biology of mixed lineage leukemia

(2009) R. K. Slany   HAEMATOLOGICA

New insights to the MLL recombinome of acute leukemias

(2009) C Meyer et al.   LEUKEMIA

Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents

(2009) Cecily A. Bennett et al.   LEUKEMIA RESEARCH

HOXA9 is required for survival in human MLL-rearranged acute leukemias

(2008) J. Faber et al.   BLOOD

Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains

(2007) Anand Mayasundari et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The AF4-mimetic peptide, PFWT, induces necrotic cell death in MV4-11 leukemia cells

(2007) Christine M. Palermo et al.   LEUKEMIA RESEARCH